About Epygen
Epygen is a Healthcare company based in Dubai (United Arab Emirates) founded in 2006. Enzymes for therapeutic and industrial applications are researched and manufactured. The company has 47 employees. Its Indian entity Epygen Biotech Private Limited reported revenue of ₹23.61 Cr. Epygen offers products and services including Oilfield Enzymes, Pulp and Paper Enzymes, Textile Enzymes, Home Care Enzymes, and Leather Enzymes. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
Epygen was founded in 2006 as a biotechnology company headquartered in Dubai, United Arab Emirates. Research and production of enzyme proteins for therapeutic and industrial sectors are conducted across multiple locations. Offices, laboratories, and manufacturing facilities are maintained in Dubai, India, and the United States. A broad spectrum of enzymes is developed to support diverse applications in these fields.
- Headquarters Dubai, United Arab Emirates
- Employees 47
- SectorsHealthcare
- Email••••••••
- Website epygen.com
- Social LinkedIn
- Legal Name Epygen Biotech Private Limited
- Date of Incorporation 25 Aug, 2011
- Jurisdiction Rasayani, Maharashtra, India
- Indian entity revenue₹23.61 Cr
FY 2025 · +138% YoY
- Indian entity net profit₹7.02 Cr
FY 2025 · 30% margin
- Indian entity EBITDA₹14.59 Cr
FY 2025 · 62% margin
- Employee Count47
Associated legal entities of Epygen
Epygen operates through Epygen Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Epygen Biotech Private Limited CIN U24233MH2011PTC221254 | Active | 25 Aug 2011 | Rasayani, Maharashtra | ₹23.6 Cr | 47 | 4 | View details |
Products & Services of Epygen
Epygen offers a comprehensive portfolio of products and services, including Oilfield Enzymes, Pulp and Paper Enzymes, Textile Enzymes, Home Care Enzymes, and Leather Enzymes.
Enzymes for breaking down biopolymers in oil extraction processes.
Enhances paper quality and productivity while saving resources.
Facilitates starch removal and simplifies textile finishing techniques.
Designed for effective cleaning at low temperatures in households.
Hydrolyzes proteins and fats for eco-friendly leather processing.
Aids in cellulose hydrolysis for efficient fermentable sugar production.
Board of directors of Epygen Biotech Private Limited (Epygen)
Epygen Biotech Private Limited is the primary company behind Epygen. The board of Epygen Biotech Private Limited currently have 4 directors; the longest-serving is Debayan Sukhamoy Ghosh, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Debayan Sukhamoy Ghosh DIN 03591159 | Director | 25 Aug 2011 | 15 yrs 2 mo | Epygen Biotech Private Limited |
| Ineeyan Vivekanandan Ariyaratnam DIN 03596235 | Director | 25 Aug 2011 | 15 yrs 2 mo | Epygen Biotech Private Limited |
| Manickam DIN 07179240 | Director | 11 Jul 2016 | 10 yrs 3 mo | Epygen Biotech Private Limited |
| Soumitro Deb DIN 08720030 | Director | 18 Mar 2020 | 6 yrs 7 mo | Epygen Biotech Private Limited |
People of Epygen
4 people are tracked at Epygen (3 in leadership, 1 in team); the tracked headcount is 47.
| Name | Role | Group |
|---|---|---|
| Director & VP | Leadership | |
| Co-Founder & President | Leadership | |
Ravi Kulkarni | Sales Director | Leadership |
Abdul Rahman | Technical Manager | Team |
Complete people profiles for Epygen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Epygen
Figures of Epygen Biotech Private Limited, the primary company behind Epygen, for FY 2025. Revenue was ₹23.61 Cr (+138% year on year). Net profit was ₹7.02 Cr (30% margin). EBITDA was ₹14.59 Cr (62% margin). Revenue has grown at a compounded annual rate of +106% over three years and +62% over five years.
- ₹23.61 CrRevenue · FY 2025 · +138% YoY
- ₹7.02 CrNet profit · 30% margin
- ₹14.59 CrEBITDA · 62% margin
- ₹14.96 CrPaid-up capital
- 47Employees (provident fund records)
- +106%Revenue CAGR, 3 years
- +62%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Epygen Biotech Private Limited are on its company page.
Detailed financial statements for Epygen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epygen
Complete news archive for Epygen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epygen
Epygen was founded in 2006.
Epygen is headquartered in Dubai, United Arab Emirates. It is registered at Dubai, Dubai, United Arab Emirates.
Epygen has 47 employees.
The primary company behind Epygen, Epygen Biotech Private Limited, reported revenue of ₹23.61 Cr for FY 2025, up 138% year on year.
Epygen was founded in 2006 as a biotechnology company headquartered in Dubai, United Arab Emirates. Research and production of enzyme proteins for therapeutic and industrial sectors are conducted across multiple locations. Offices, laboratories, and manufacturing facilities are maintained in Dubai, India, and the United States. A broad spectrum of enzymes is developed to support diverse applications in these fields.
Epygen offers Oilfield Enzymes, Pulp and Paper Enzymes, Textile Enzymes, Home Care Enzymes, and 2 more products and services.
Epygen operates through Epygen Biotech Private Limited.
The legal entities of Epygen currently have 4 directors, including Debayan Sukhamoy Ghosh, Ineeyan Vivekanandan Ariyaratnam, Soumitro Deb and others.